Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 97

Similar articles for PubMed (Select 1100566)

1.

Isometheptene--a non-ergot drug in the treatment of migraine.

Diamond S, Medina JL.

Headache. 1975 Oct;15(3):211-3. No abstract available.

PMID:
1100566
2.

A double-blind crossover trial of isometheptene mucate compound and ergotamine in migraine.

Yuill GM, Swinburn WR, Liversedge LA.

Br J Clin Pract. 1972 Feb;26(2):76-9. No abstract available.

PMID:
4552744
3.

Pharmacologic treatment of recurrent pediatric headache.

Graf WD, Riback PS.

Pediatr Ann. 1995 Sep;24(9):477-84. Review. No abstract available.

PMID:
8552424
4.

Comparative study of a combination of isometheptene mucate, dichloralphenazone with acetaminophen and sumatriptan succinate in the treatment of migraine.

Freitag FG, Cady R, DiSerio F, Elkind A, Gallagher RM, Goldstein J, Klapper JA, Rapoport AM, Sadowsky C, Saper JR, Smith TR.

Headache. 2001 Apr;41(4):391-8.

PMID:
11318886
5.

Drug treatment of migraine headache.

Calesnick B.

Am Fam Physician. 1982 May;25(5):228-30. No abstract available.

PMID:
7072580
6.

[Clinical use of a new sympathomimetic amine, dimethoprine].

Arcidiacono R, Sanna GP.

Minerva Cardioangiol. 1972 Sep;20(9):526-35. Italian. No abstract available.

PMID:
5071473
7.
8.

Intracerebral hemorrhage in postpartum cerebral angiopathy associated with the use of isometheptene.

Campos CR, Yamamoto FI.

Int J Gynaecol Obstet. 2006 Nov;95(2):151-2. Epub 2006 Sep 25. No abstract available.

PMID:
16999965
9.

Pharmacological profile of the mechanisms involved in the external carotid vascular effects of the antimigraine agent isometheptene in anaesthetised dogs.

Willems EW, Valdivia LF, Saxena PR, Villalón CM.

Naunyn Schmiedebergs Arch Pharmacol. 2001 Jul;364(1):27-32.

PMID:
11485035
10.

[Deseril (methysergide) in the treatment of vascular migraine headache].

Zec N, Bokonjić R.

Neuropsihijatrija. 1964;12(1-4):137-45. Bosnian. No abstract available.

PMID:
16305167
12.

Oral sumatriptan in acute migraine.

Goadsby PJ, Zagami AS, Donnan GA, Symington G, Anthony M, Bladin PF, Lance JW.

Lancet. 1991 Sep 28;338(8770):782-3.

PMID:
1681162
13.

Treatment of migraine.

[No authors listed]

Practitioner. 1971 Apr;206(234):551-4. No abstract available.

PMID:
4930722
14.

A study of midrin in the symptomatic relief of migraine headache.

Ryan RE.

Headache. 1974 Apr;14(1):33-42. No abstract available.

PMID:
4599014
15.

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH.

Neurology. 2000 Jan 11;54(1):156-63.

PMID:
10636142
16.

How to assess patient preference of migraine treatments.

Dahlöf C.

Cephalalgia. 1999 Jul;19 Suppl 24:2-5; discussion 5-6. No abstract available.

PMID:
10526675
17.

Oral sumatriptan in the acute treatment of migraine and migraine recurrence in general practice.

Scott RJ, Aitchison WR, Barker PR, McLaren GI.

QJM. 1996 Aug;89(8):613-22.

18.

[Etiology and treatment of migraine].

Petelin LS, Shtok VN, Pigarev VA.

Sov Med. 1976 Nov;(11):62-5. Russian. No abstract available.

PMID:
1006395
19.

[Treatment of transformed refractory migraine with intravenous dihydroergotamine].

Cid C, Ortega-Valín F, Valero M, Muñoz R, Pascual J.

Neurologia. 1999 Jun-Jul;14(6):315-8. Spanish.

PMID:
10439626
20.

[Evaluation of efficacy and tolerance sumatriptan at a dose of 50 mg in treatment of migraine attack].

Prusiński A, Król F.

Pol Merkur Lekarski. 1998 Mar;4(21):158-61. Polish.

PMID:
9640070
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk